Tharimmune Inc.
Biotechnology
Healthcare
THAR
2.88 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.91
52 week high
7.71
high
2.92
52 week low
0.00
low
2.82
growth
-0.70 %
previous Close
2.91
P/E ratio
market cap
26.22 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-1.86 M
27.01 %
eps
0.00 %
35.35 %
eps surprise
0.00 %
net profit margin
-185515300.00 %
0.00 %
operating incoming
-1.85 M
27.31 %
net change in cash
1.17 M
146.95 %
cash on hand
2.24 M
108.38 %
cost of revenue
0.00 %
top top